Blood Disease - First Patient in Germany Treated with Gene Scissors

TL;DR AI-generated A 19-year-old with beta-thalassemia has become the first patient in Germany to be treated with the gene-editing therapy Exa-cel. Following treatment with genetically modified stem cells, blood transfusions are no longer necessary. Long-term data on the therapy's safety and efficacy are not yet available.